🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the efficacy and safety of TAS-102 ...
Status
Completed
Location
Arizona Center for Cancer Care
Start Date
2012-06-17
Trial ID
NCT01607957
This study will compare how safe and effective sacituzumab tirumotecan is v...
Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0119)
Start Date
2024-05-03
Trial ID
NCT06356311
The purpose of the study is to characterize the safety and pharmacokinetic ...
Status
Completed
Location
Onc001 50414
Start Date
2020-07-09
Trial ID
NCT04393298
Treatments Being Tested
The purpose of this study is to collect additional safety and efficacy data...
Status
Completed
Location
Chris O'Brien Lifehouse Oncology
Start Date
2016-10-18
Trial ID
NCT03306394
Treatments Being Tested
Immune therapies work with the body's immune system to treat a number of ca...
Status
Terminated
Location
Providence Medical Foundation
Start Date
2021-10-19
Trial ID
NCT05083481
ASP1002 is being studied in people with tumors that have spread to nearby t...
Status
Recruiting
Location
Yale University Cancer Center
Start Date
2023-03-13
Trial ID
NCT05719558
The purpose of this study is to evaluate, in patients with advanced solid t...
Status
Completed
Location
University of Pittsbutgh Cancer Institute
Start Date
2014-02
Trial ID
NCT02031055
The purpose of this study is to evaluate the efficacy of S 95005 in patient...
Status
Completed
Location
Russian Cancer Research Center n.a. NN Blokhin (RCRC), Clinical Pharmacology and Chemotherapy department
Start Date
2017-03-03
Trial ID
NCT03274882
Treatments Being Tested
This study aims to address the unmet medical need of participants with meta...
Status
Recruiting
Location
Rocky Mountain Cancer Centers, LLP- Aurora
Start Date
2026-05-06
Trial ID
NCT07549412
Treatments Being Tested
The main purpose of this study is to evaluate the progression-free survival...
Status
Completed
Location
Chris O'Brien Lifehouse Oncology
Start Date
2016-04-29
Trial ID
NCT02743221
Treatments Being Tested